WHO Declares MPOX No Longer International Emergency
- Teh World health Organization (WHO) announced on May 11, 2023, that mpox (formerly known as monkeypox) is no longer considered a Public Health Emergency of International Concern (PHEIC).
- the initial PHEIC declaration was made on July 23, 2022, in response to the rapid spread of mpox across multiple countries, primarily affecting men who have sex with...
- While the emergency phase has ended, the WHO emphasizes that mpox remains a public health issue requiring continued vigilance.
MPXV No Longer a Global Health emergency, WHO Declares
Table of Contents
End of Public Health Emergency Status
Teh World health Organization (WHO) announced on May 11, 2023, that mpox (formerly known as monkeypox) is no longer considered a Public Health Emergency of International Concern (PHEIC). This declaration, as reported by multiple news sources including the WHO’s official statement, signifies a ample decrease in the global risk posed by the virus.
the initial PHEIC declaration was made on July 23, 2022, in response to the rapid spread of mpox across multiple countries, primarily affecting men who have sex with men. This triggered a coordinated international response focused on containment and vaccine distribution.
Current Situation and Ongoing Vigilance
While the emergency phase has ended, the WHO emphasizes that mpox remains a public health issue requiring continued vigilance. The virus is still circulating, particularly in certain regions, and sporadic cases continue to be reported globally. the Centers for Disease Control and Prevention (CDC) provides ongoing updates on case numbers and transmission patterns.
The WHO stresses the importance of maintaining surveillance systems,continuing vaccination efforts,and providing access to care for those infected. Focus is now shifting towards longer-term control strategies, integrating mpox prevention and treatment into existing healthcare infrastructure.
Impact of Vaccination and Public Health Measures
The decline in cases is largely attributed to the prosperous implementation of vaccination campaigns and public health interventions. Vaccines, such as the JYNNEOS vaccine, have proven highly effective in preventing mpox infection and reducing the severity of illness. The U.S. Food and Drug Administration (FDA) approved JYNNEOS for mpox prevention in August 2022.
Public health messaging promoting safe sexual practices and awareness of symptoms also played a crucial role in curbing the outbreak. Early detection and isolation of cases helped to limit further transmission.
Looking Ahead: Long-Term Management
The WHO’s decision to lift the PHEIC does not mean mpox has been eradicated. Instead, it signals a transition to a more sustainable approach to managing the disease. This includes strengthening national capacities for surveillance, diagnosis, and treatment, as well as addressing the social and behavioral factors that contribute to transmission.
Continued research is also essential to better understand the virus,develop more effective vaccines and treatments,and prevent future outbreaks. The global health community remains committed to working together to protect populations from the ongoing threat of mpox.